Princeton Capital Management LLC Incyte Corp Transaction History

Princeton Capital Management LLC

$318 Million
Q4 2024

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$57.33 - $68.61 $184,143 - $220,375	-3,212 Reduced 43.94%	4,098 $270,000
Q2 2024 Aug 01, 2024	SELL	$51.18 - $63.75 $182,661 - $227,523	-3,569 Reduced 32.81%	7,310 $443,000
Q1 2024 May 09, 2024	SELL	$56.55 - $66.59 $77,530 - $91,294	-1,371 Reduced 11.19%	10,879 $619,000
Q4 2023 Feb 08, 2024	SELL	$52.16 - $64.19 $147,769 - $181,850	-2,833 Reduced 18.78%	12,250 $769,000
Q3 2023 Nov 13, 2023	SELL	$57.77 - $65.93 $9,127 - $10,416	-158 Reduced 1.04%	15,083 $871,000
Q2 2023 Aug 14, 2023	SELL	$60.95 - $75.51 $45,224 - $56,028	-742 Reduced 4.64%	15,241 $948,000
Q1 2023 May 01, 2023	SELL	$70.23 - $86.01 $29,988 - $36,726	-427 Reduced 2.6%	15,983 $1.16 Million
Q4 2022 Jan 31, 2023	SELL	$67.18 - $84.11 $32,515 - $40,709	-484 Reduced 2.86%	16,410 $1.32 Million
Q3 2022 Nov 10, 2022	BUY	$66.18 - $82.86 $43,480 - $54,439	657 Added 4.05%	16,894 $1.13 Million
Q2 2022 Aug 15, 2022	SELL	$66.18 - $83.18 $397 - $499	-6 Reduced 0.04%	16,237 $1.23 Million
Q1 2022 May 11, 2022	SELL	$66.02 - $79.71 $85,627 - $103,383	-1,297 Reduced 7.39%	16,243 $1.29 Million
Q4 2021 Feb 09, 2022	BUY	$63.34 - $74.11 $22,359 - $26,160	353 Added 2.05%	17,540 $1.29 Million
Q3 2021 Nov 10, 2021	BUY	$68.67 - $84.02 $77,597 - $94,942	1,130 Added 7.04%	17,187 $1.18 Million
Q2 2021 Aug 11, 2021	BUY	$79.87 - $87.53 $67,490 - $73,962	845 Added 5.55%	16,057 $1.35 Million
Q1 2021 May 12, 2021	BUY	$76.02 - $100.5 $53,214 - $70,350	700 Added 4.82%	15,212 $1.24 Million
Q4 2020 Feb 11, 2021	SELL	$80.74 - $97.7 $189,254 - $229,008	-2,344 Reduced 13.91%	14,512 $1.26 Million
Q3 2020 Nov 12, 2020	BUY	$85.07 - $109.69 $111,781 - $144,132	1,314 Added 8.45%	16,856 $1.51 Million
Q2 2020 Aug 10, 2020	BUY	$74.18 - $108.93 $276,320 - $405,764	3,725 Added 31.52%	15,542 $1.62 Million
Q1 2020 May 13, 2020	BUY	$63.18 - $85.97 $110,122 - $149,845	1,743 Added 17.3%	11,817 $1.14 Million
Q4 2019 Feb 12, 2020	BUY	$73.04 - $95.72 $171,644 - $224,942	2,350 Added 30.42%	10,074 $747,000
Q3 2019 Nov 14, 2019	BUY	$72.82 - $86.52 $51,046 - $60,650	701 Added 9.98%	7,724 $573,000
Q2 2019 Aug 12, 2019	BUY	$73.52 - $88.7 $55,213 - $66,613	751 Added 11.97%	7,023 $597,000
Q1 2019 May 02, 2019	SELL	$63.56 - $88.17 $18,368 - $25,481	-289 Reduced 4.4%	6,272 $539,000
Q4 2018 Feb 13, 2019	SELL	$58.5 - $69.94 $239,323 - $286,124	-4,091 Reduced 38.41%	6,561 $417,000
Q3 2018 Nov 08, 2018	SELL	$61.75 - $74.23 $23,526 - $28,281	-381 Reduced 3.45%	10,652 $736,000
Q2 2018 Aug 02, 2018	SELL	$60.85 - $83.98 $9,796 - $13,520	-161 Reduced 1.44%	11,033 $739,000
Q1 2018 May 03, 2018	BUY	$83.06 - $100.98 $218,115 - $265,173	2,626 Added 30.65%	11,194 $933,000
Q4 2017 Feb 12, 2018	BUY	$93.56 - $116.6 $801,622 - $999,028	8,568	8,568 $811,000

Others Institutions Holding INCY

# of Institutions

697

Shares Held

188M

Call Options Held

585K

Put Options Held

410K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $15.7B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Princeton Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Princeton Capital Management LLC with notifications on news.

Account